HomeCompareBCDS vs MRK

BCDS vs MRK: Dividend Comparison 2026

BCDS yields 45662.10% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCDS wins by $1.9378762937613886e+23M in total portfolio value
10 years
BCDS
BCDS
● Live price
45662.10%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.9378762937613886e+23M
Annual income
$192,956,361,509,254,000,000,000,000,000.00
Full BCDS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BCDS vs MRK

📍 BCDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCDSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCDS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCDS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCDS
Annual income on $10K today (after 15% tax)
$3,881,278.54/yr
After 10yr DRIP, annual income (after tax)
$164,012,907,282,865,900,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, BCDS beats the other by $164,012,907,282,865,900,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCDS + MRK for your $10,000?

BCDS: 50%MRK: 50%
100% MRK50/50100% BCDS
Portfolio after 10yr
$9.689381468806943e+22M
Annual income
$96,478,180,754,627,000,000,000,000,000.00/yr
Blended yield
99.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BCDS
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
-1.2
Piotroski
2/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCDS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCDSMRK
Forward yield45662.10%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.9378762937613886e+23M$57.7K
Annual income after 10y$192,956,361,509,254,000,000,000,000,000.00$10,113.78
Total dividends collected$1.9373304284021552e+23M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: BCDS vs MRK ($10,000, DRIP)

YearBCDS PortfolioBCDS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$4,576,910$4,566,210.05$11,213$373.04+$4.57MBCDS
2$1,958,087,259$1,953,189,965.29$12,667$512.06+$1958.07MBCDS
3$783,040,014,272$780,944,860,905.09$14,439$708.14+$783040.00MBCDS
4$292,707,214,080,582$291,869,361,265,310.25$16,640$988.16+$292707214.06MBCDS
5$102,278,919,163,744,560$101,965,722,444,678,340.00$19,432$1,394.07+$102278919163.73MBCDS
6$33,407,820,094,773,314,000$33,298,381,651,268,110,000.00$23,057$1,992.90+$33407820094773.29MBCDS
7$10,200,605,333,169,543,000,000$10,164,858,965,668,135,000,000.00$27,889$2,894.79+$10200605333169544.00MBCDS
8$2,911,565,030,490,926,600,000,000$2,900,650,382,784,435,000,000,000.00$34,518$4,286.29+$2911565030490926592.00MBCDS
9$776,885,856,901,758,600,000,000,000$773,770,482,319,133,300,000,000,000.00$43,912$6,494.35+$776885856901758582784.00MBCDS
10$193,787,629,376,138,880,000,000,000,000$192,956,361,509,254,000,000,000,000,000.00$57,714$10,113.78+$1.9378762937613886e+23MBCDS

BCDS vs MRK: Complete Analysis 2026

BCDSStock

Blaqclouds Inc. develops software as a service solutions. The company's products include BlaqPromote for business owners to segment their customer databases; BlaqStats that provides insightful data from Website to make data-based decisions; and BlaqTrax that enables business owners to monitor staff remotely. Its products also comprise Geo BlaqTrax that allows business owners to monitor the whereabouts of mobile staff without any installable hardware or software; and BlaqBiz, a business management system. The company is based in Los Angeles, California.

Full BCDS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BCDS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCDS vs SCHDBCDS vs JEPIBCDS vs OBCDS vs KOBCDS vs MAINBCDS vs JNJBCDS vs ABBVBCDS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.